Has Shylaja Prashanth, MD received payments from drug or device companies?

Yes. Drug and device makers reported $232 in general payments to Shylaja Prashanth, MD across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shylaja Prashanth, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shylaja Prashanth, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shylaja Prashanth, MD

Rheumatology · Campbell, CANPI 1720263825

Payments from drug & device makers

$232in general payments, 2019–2025

Across 3 payments — averaging $77.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$154
AbbVie$78

What the payments were for

Food & beverage$232100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	2	$154
AbbVie	1	$78

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KRYSTEXXA$137

How this compares

$232 in reported general payments places this provider in the 20th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Medicare billing

Part B allowed, 2024

$371,236

Medicare patients

365

Services billed

18,875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Sensoready PenSecukinumab	16	$119,586
Enbrel SureclickEtanercept	13	$95,772
BenlystaBelimumab	13	$62,969
Teriparatide	27	$56,217
TymlosAbaloparatide	11	$28,864
Celecoxib	67	$6,188
MethotrexateMethotrexate Sodium	113	$4,739
Hydroxychloroquine Sulfate	64	$3,929
Mycophenolate Mofetil	14	$3,226
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	47	$3,047
Leflunomide	42	$2,627
Gabapentin	81	$2,099
Colchicine	26	$2,096
Febuxostat	12	$1,578
Famotidine	67	$1,482

Paid to pharmacies, not to this prescriber.

Other rheumatology in Campbell

Samy MetyasCovina$12.9M
Christine ThaiHuntington Beach$8.5M
Tien-I SuWhittier$8.4M
Eric LeeUpland$6.9M
Orrin TroumSanta Monica$6.9M
Shirley PangFullerton$5.7M
William RobinsonStanford$5.1M
Dan laTujunga$5.1M
Christina Charles-SchoemanLos Angeles$4.8M
Suneet GrewalWest Hollywood$3.8M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →